BPC 157 + TB-500 - 10mG

  • Quantity: 20mg total per vial

    • BPC-157: 10mg

    • TB-500: 10mg

  • Form: Lyophilized multi-peptide powder

  • Packaging: Secure, sealed, and tamper-proof sterile vial

  • Source: High-quality lab-grade peptides, independently third-party tested

  • Purity: ≥98% (HPLC and mass spectrometry verified)

  • Note: This product is sold in powder form and must be reconstituted prior to laboratory use

Overview of Wolverine’s Research Profile

Wolverine is a dual-peptide research formulation combining BPC-157 and TB-500, two extensively studied peptides known for their complementary roles in tissue regeneration, cell migration, and structural repair signaling within controlled laboratory environments.

This combination is designed to allow researchers to investigate synergistic peptide interactions across multiple regenerative pathways. BPC-157 is frequently examined for its influence on angiogenesis, tendon and ligament signaling, and cellular survival mechanisms, while TB-500 is studied for its role in actin regulation, cytoskeletal remodeling, and enhanced cellular motility.

Together, these peptides provide a robust model for studying coordinated repair processes, making Wolverine a valuable formulation for advanced regenerative and recovery-focused research.

Research Specifics

Wolverine has been explored in non-clinical research for its involvement in:

  • Tissue Repair Pathway Modeling:

    • BPC-157 supports studies involving vascular signaling and connective tissue response

    • TB-500 enhances research into actin-mediated cell migration and repair dynamics

  • Angiogenesis and Blood Flow Research:

    • Investigation of peptide-driven vascular growth and perfusion signaling

  • Cellular Migration and Remodeling:

    • TB-500-mediated actin upregulation and cytoskeletal organization studies

  • Synergistic Peptide Interaction Analysis:

    • Combined effects of regenerative peptides on structural and signaling pathways

Key Features

  • Peptide Composition: Dual-peptide regenerative research blend

  • Total Content: 20mg per vial (10mg BPC-157 + 10mg TB-500)

  • Form: Lyophilized powder for reconstitution

  • Purity: ≥98% research-grade

  • Laboratory Stability: Optimized for extended experimental protocols when stored appropriately

Potential Applications

Researchers may explore Wolverine in studies involving:

  • Connective tissue regeneration modeling

  • Tendon and ligament signaling research

  • Actin-driven cellular migration studies

  • Angiogenesis and vascular repair pathways

  • Multi-peptide synergy and repair optimization research

Specifications

This product is supplied in a sterile, tamper-evident vial to preserve molecular integrity and purity. Reconstitution should be performed using appropriate laboratory-grade diluents and standard peptide-handling protocols. Proper cold storage is recommended to maintain stability.

Note

  • This product is intended solely for research and scientific purposes, including use by scientists, researchers, and other qualified individuals.

  • Images provided are for reference only and may differ from the actual product supplied.

  • Outcomes and applications are dependent on proper usage. Always adhere to required protocols and handle all materials responsibly. Misuse of this product is discouraged.

  • Reconstituting peptides with Bacteriostatic Water is a critical practice for achieving reliable research results.

Legal Disclaimer

This product is intended solely for laboratory and research purposes. They are not for human or animal use. Purchasers must comply with all applicable laws and regulations. By purchasing, you agree to indemnify and hold harmless our company from any claims arising from the handling or use of these products. Our liability is limited to the purchase price. Adopt all necessary safety precautions when handling the products. All product information and handling information is for informational/research purposes only.  This is governed under Canadian law.

Shipping across Canada, including but not limited to: British Columbia (Victoria, Vancouver, Surrey, Burnaby), Alberta (Edmonton, Calgary, Strathcona County), Saskatchewan (Regina, Saskatoon, Prince Albert), Manitoba (Winnipeg, Brandon), Ontario (Toronto, Ottawa, Mississauga, Hamilton), Quebec (Québec City, Montréal, Laval, Gatineau), New Brunswick (Fredericton, Saint John, Moncton), Nova Scotia (Halifax, Sydney), Prince Edward Island (Charlottetown, Summerside), Newfoundland and Labrador (St. John’s, Conception Bay South), Yukon (Whitehorse, Dawson City), Northwest Territories (Yellowknife, Hay River), Nunavut (Iqaluit, Arviat).